Inventor · disambiguated record
Anthony W. Shaw
Also filed as: SHAW ANTHONY · SHAW ANTHONY W
31 granted patents·10 pending applications·421 citations·filing 1996–2024
97Inventor score
Files withMERCK & CO INC15SIRNA THERAPEUTICS INC9MERCK SHARP & DOHME LLC6MERCK SHARP & DOHME4AARONSON JEFFREY G1
Top patents by PatentIndex Score
41 records- 0194US7452903B2CGRP receptor antagonistsMERCK & CO INC·Filed 2007·Granted Nov 18, 2008·22 cites·6 claims
- 0294US7235545B2CGRP receptor antagonistsMERCK & CO INC·Filed 2005·Granted Jun 26, 2007·22 cites·4 claims
- 0392US7772224B2CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2009·Granted Aug 10, 2010·14 cites·16 claims
- 0492US6953790B2CGRP receptor antagonistsMERCK & CO INC·Filed 2004·Granted Oct 11, 2005·36 cites·22 claims
- 0591US7491713B2CGRP receptor antagonistsMERCK & CO INC·Filed 2005·Granted Feb 17, 2009·11 cites·12 claims
- 0690US8039460B2CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2005·Granted Oct 18, 2011·19 cites·11 claims
- 0789US6127366AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1998·Granted Oct 3, 2000·54 cites·22 claims
- 0889US5817678AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1996·Granted Oct 6, 1998·57 cites·23 claims
- 0988US11117917B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2019·Granted Sep 14, 2021·2 cites·20 claims
- 1086US9540639B2Tetragalnac containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2013·Granted Jan 10, 2017·10 cites·22 claims
- 1185US8598209B2P2X3, receptor antagonists for treatment of painBURGEY CHRISTOPHER S·Filed 2009·Granted Dec 3, 2013·8 cites·16 claims
- 1285US7994325B2CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2006·Granted Aug 9, 2011·9 cites·7 claims
- 1385US6297239B1Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 1998·Granted Oct 2, 2001·67 cites·31 claims
- 1484US10221205B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Mar 5, 2019·3 cites·20 claims
- 1584US9655976B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2013·Granted May 23, 2017·6 cites·35 claims
- 1684US7732438B2CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2005·Granted Jun 8, 2010·9 cites·6 claims
- 1779US7205292B2CGRP receptor antagonistsMERCK & CO INC·Filed 2004·Granted Apr 17, 2007·9 cites·22 claims
- 1878US6350755B1Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 2001·Granted Feb 26, 2002·9 cites·18 claims
- 1977US12304925B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2021·Granted May 20, 2025·0 cites·20 claims
- 2077US6566385B2Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 2001·Granted May 20, 2003·8 cites·22 claims
- 2176US6525074B2Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 2001·Granted Feb 25, 2003·8 cites·28 claims
- 2272US8691580B2Single chemical entities and methods for delivery of oligonucleotidesAARONSON JEFFREY G·Filed 2011·Granted Apr 8, 2014·2 cites·6 claims
- 2371US7893052B2CGRP receptor antagonistsPAONE DANIEL VINCENT·Filed 2010·Granted Feb 22, 2011·2 cites·15 claims
- 2471US6413964B1Inhibitors of prenyl-protein transferaseFiled 2001·Granted Jul 2, 2002·6 cites·18 claims
- 2567US9840531B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Dec 12, 2017·0 cites·21 claims
- 2665US2025312362A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2763US2025026759A1Tetrahydroquinazoline derivatives as selective cytotoxic agentsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 2862US6284755B1Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 1999·Granted Sep 4, 2001·16 cites·35 claims
- 2961US11648250B2Tetrahydroquinazoline derivatives as selective cytotoxic agentsMERCK SHARP & DOHME LLC·Filed 2021·Granted May 16, 2023·0 cites·30 claims
- 3061US2025326713A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3160US6127390AInhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 1998·Granted Oct 3, 2000·8 cites·18 claims
- 3259US2025051341A1Pyrazolopyrimidine derivatives and methods of use thereof for the treatment of herpesvirusesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 3358US2017137815A1Novel single chemical entities and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3457US12492183B2Tetrahydroquinazoline derivatives as selective cytotoxic agentsMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 9, 2025·0 cites·25 claims
- 3556US2024083910A1Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesvirusesBERGER RICHARD·Filed 2021·Application pending·0 cites
- 3655US2016074525A1Novel single chemical entities and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3754US2013253168A1Novel single chemical entities and methods for delivery of oligonucleotidesCOLLETTI STEVEN L·Filed 2011·Application pending·0 cites
- 3854US2024067657A1Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesvirusesARMACOST KIRA A·Filed 2021·Application pending·0 cites
- 3950US6316436B1Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 1999·Granted Nov 13, 2001·4 cites·17 claims
- 4046US10214742B2Tetragalnac containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·0 cites·20 claims
- 4146US2002037888A1Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anthony W. Shaw files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →